Literature DB >> 12949515

Angiogenesis inhibitors and hypoxia.

Mark W Kieran, Judah Folkman, John Heymach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12949515     DOI： 10.1038/nm0903-1104a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  VEGF inhibition and metastasis: possible implications for antiangiogenic therapy.

Authors:  Bevin C English; Douglas K Price; William D Figg
Journal:  Cancer Biol Ther       Date:  2009-07-04       Impact factor: 4.742

2.  Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids.

Authors:  N M Fletcher; M G Saed; H M Abu-Soud; A Al-Hendy; M P Diamond; G M Saed
Journal:  J Assist Reprod Genet       Date:  2013-06-30       Impact factor: 3.412

3.  Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mRNA splicing.

Authors:  Guang Xu; Ting Li; Jiayi Chen; Changyan Li; Haixin Zhao; Chengcheng Yao; Hua Dong; Kaiqing Wen; Kai Wang; Jie Zhao; Qing Xia; Tao Zhou; Huafeng Zhang; Ping Gao; Ailing Li; Xin Pan
Journal:  Autophagy       Date:  2018-08-13       Impact factor: 16.016

4.  Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis.

Authors:  Ivan L Cameron; Lu-Zhe Sun; Nicholas Short; W Elaine Hardman; C Douglas Williams
Journal:  Cancer Cell Int       Date:  2005-07-26       Impact factor: 5.722

5.  Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.

Authors:  Xiaoqing Jia; Qi Hong; Li Lei; Daqiang Li; Jianwei Li; Miao Mo; Yujie Wang; Zhimin Shao; Zhenzhou Shen; Jingyi Cheng; Guangyu Liu
Journal:  Oncotarget       Date:  2015-04-20

6.  Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Gene Regul Syst Bio       Date:  2007-10-14

Review 7.  Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?

Authors:  Shuai Wang; Zhe Yang; Zhou Wang
Journal:  Oncotarget       Date:  2015-07-20

Review 8.  Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.